Scientific Advisory Panel on Opioids (SAP-Opioids)
Agenda for November 15th & 16th, 2016
Place: Holland Cross, Tower B, 5th floor, Room 5118
Date and Time: November 15th and 16th, 2016; 9:00am to 4:00pm, EST
Chairperson: Jason Busse
Science Advisor: Conrad Pereira
Science and Regulatory Supervisor: Larissa Lefebvre
Participants: SAP-Opioids members, Health Canada employees, Guest speaker(s)
Number | TimeFootnote * | Description |
---|---|---|
1. | 9:00-09:15 | Welcome and Opening remarks Marion Law, Director General, Therapeutic Products Directorate (TPD) |
2. | 9:15-09:30 | Introduction of Members, Review of Affiliations and Interests Declarations, Chair's address, Review of Agenda Chair |
3. | 9:30-10:30 | Health Canada presentation Bureau of Cardiology, Allergy and Neurological Sciences (BCANS), TPD |
4. | 10:30-10:45 | Coffee/tea Break |
5. | 10:45-11:30 | Guest Speaker Presentation Institute for Safe Medication Practices Canada |
6. | 11:30-12:00 | Health Canada presentation Therapeutic Effectiveness and Policy Bureau, Marketed Health Products Directorate (MHPD) |
7. | 12:00-1:00 | Lunch |
8. | 1:00-4:00 | Deliberations of Questions and Answers SAP-Opioids members |
Number | TimeFootnote * | Description |
---|---|---|
1. | 9:00-10:00 | Health Canada presentation (Classification) Marketed Pharmaceuticals and Medical Devices Bureau, MHPD |
2. | 10:30-10:45 | Health Canada presentation (Risk Management Plan) Marketed Pharmaceuticals and Medical Devices Bureau, MHPD |
3. | 10:45-11:00 | Coffee/tea Break |
4. | 11:00-12:30 | Deliberations of Questions and Answers SAP-Opioids members |
5. | 12:30-1:15 | Lunch |
6. | 1:15-3:15 | Deliberations of Questions and Answers SAP-Opioids members |
7. | 3:15-3:30 | Closing Remarks and Adjournment of Meeting Chair |
Page details
- Date modified: